Grantham, Mayo, Van Otterloo & Co (GMO)’s Clorox CLX Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-7,721	Closed	-$1.49M	–	734
2021 Q1	$1.49M	Hold	7,721	–	–	0.01%	521
2020 Q4	$1.56M	Sell	7,721 -4,871	-39%	-$1.01M	0.01%	483
2020 Q3	$2.65M	Buy	12,592 +11,580	+1,144%	+$2.58M	0.02%	359
2020 Q2	$222K	Buy	+1,012	New	+$202K	﹤0.01%	701
2018 Q3	–	Sell	-3,500	Closed	-$473K	–	537
2018 Q2	$473K	Sell	3,500 -33,000	-90%	-$4.07M	﹤0.01%	472
2018 Q1	$4.86M	Sell	36,500 -100	-0.3%	-$13.4K	0.03%	230
2017 Q4	$5.44M	Buy	36,600 +2,100	+6%	+$286K	0.03%	221
2017 Q3	$4.55M	Buy	+34,500	New	+$4.64M	0.03%	230
2014 Q4	–	Sell	-9,700	Closed	-$932K	–	446
2014 Q3	$932K	Sell	9,700 -31,500	-76%	-$2.85M	﹤0.01%	387
2014 Q2	$3.77M	Sell	41,200 -8,400	-17%	-$752K	0.01%	310
2014 Q1	$4.37M	Sell	49,600 -32,204	-39%	-$2.83M	0.01%	316
2013 Q4	$7.59M	Sell	81,804 -4,248	-5%	-$383K	0.02%	243
2013 Q3	$7.03M	Sell	86,052 -13,821	-14%	-$1.17M	0.02%	249
2013 Q2	$8.3M	Buy	+99,873	New	+$8.59M	0.02%	226

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

CRC

Cedar Rock Capital London, United Kingdom $4.05B AUM 21.89% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s CLX Position: Q2 2021 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Clorox (CLX) in Q2 2021, closing a stake of 7,721 shares — an estimated $1.49M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CLX in Q2 2013 and held it in 14 quarters. The position peaked at $8.3M in Q2 2013. 1,170 funds tracked by Wall St. Rank hold CLX as of Q2 2021.

Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Clorox position as of Q2 2021 after selling out during the quarter.
Grantham, Mayo, Van Otterloo & Co (GMO) sold 7,721 Clorox shares in Q2 2021, an estimated $1.49M.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Clorox in Q2 2013 and held it in 14 quarters.
Grantham, Mayo, Van Otterloo & Co (GMO)'s Clorox position peaked at $8.3M in Q2 2013.
1,170 funds tracked by Wall St. Rank held Clorox as of Q2 2021.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2021, filed 12 Aug 2021.